Key result
MVP patients with stroke show ~62% lower prevalence of ≥moderate MR than those without.
Why the study?
Mitral valve prolapse is linked to ischemic stroke, but specific risk factors for MVP-stroke subtypes are not well defined.
Case-Control (n=66)
Blinded evaluators
No
In patients with mitral valve prolapse, significant mitral regurgitation may be protective against stroke, while non-cryptogenic stroke is driven by traditional risk factors like hypertension and obesity rather than leaflet thickness.
May suggest protective role for moderate mitral regurgitation in mitral valve prolapse; hypothesis-generating and should not change practice.
Background and purpose: Mitral valve prolapse (MVP) has been associated with an increased risk of ischemic stroke. Older age, thicker mitral leaflets, and significant mitral regurgitation (MR) leading to atrial fibrillation have been traditionally considered risk factors for ischemic stroke in MVP. However, specific risk factors for MVP-stroke subtypes are not well defined. The aim of this study is to evaluate clinical and echocardiographic parameters, including left atrial (LA) function, in MVP with cryptogenic (C) vs. non-cryptogenic (NC) stroke. Methods: In this case-control matched study, MVPs were identified in consecutive echocardiograms obtained after a stroke from January 2013 to December2016 at the University of California, San Francisco. MVP was defined as leaflet displacement ≥2 mm in the parasternal long-axis view at end-systole. Age/gender matched MVPs without stroke and healthy controls without MVP were also identified. We analyzed LA end-systolic/diastolic volume index, emptying fraction (LAEF), function index (LAFI), and global longitudinal strain in all MVPs and controls. We also measured left ventricular (LV) volume indexes, mass index, ejection fraction (EF), degree of MR and leaflet thickness. Results: < 0.05) when compared to MVPs with stroke. Leaflet thickness was overall mild (<3 mm) and similar in the 2 groups. Within the MVP stroke group, NC-stroke had higher BMI, more hypertension and more atrial fibrillation compared to C-stroke. In the variables tested, patients with C-stroke did not differ from controls. Conclusions: MVP-related MR may be protective against stroke despite abnormal LA function. Risk of NC-stroke in MVP is related to common stroke risk factors rather than mitral valve leaflet thickness. The etiology of C-stroke in MVP warrants further studies.
No takes yet. Share an insight, caveat, or question.
Calicchio et al. (2023) conducted a case-control in Mitral valve prolapse and stroke (n=66). Ischemic stroke in patients with mitral valve prolapse vs. Mitral valve prolapse without stroke was evaluated on Presence of ≥moderate mitral regurgitation (p=<0.05). Patients with mitral valve prolapse and stroke had a significantly lower prevalence of ≥moderate mitral regurgitation (17%) compared to matched patients without stroke (45%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: